Since BCRP and MRP inhibitors were not synergistic (data not shown), we also hypothesize that MRP1 and BCRP act cooperatively to promote efflux in ascites-derived ovarian cancer cells, a topic for future studies. The gene discussed is ABCG2; the disease is ovarian cancer.